“PureTech has the scientific creativity to really go for the big ideas that can be game changers. The team dreams up technologies and then makes them happen”
- Dr. Robert Langer, PureTech Co-Founder & Non-Executive Director
PureTech and its programs have attracted over $450M in funding and have active strategic partnerships with some of the most forward-thinking health and technology companies in the world. Our robust pipeline – including 20 clinical studies – is focused on addressing some of society’s largest healthcare needs in multi-billion-dollar market segments at the intersection of the brain, gut and immune system.